Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Cagrilintide and retatrutide combination therapy enhances weight loss and metabolic outcomes in obese rats


ABSTRACT: This study evaluates whether simultaneously activating five key metabolic hormone receptors can outperform current peptide therapies for obesity. Using diet‑induced obese rats, we test the combined administration of retatrutide, a GLP‑1, GIP, and glucagon triagonist, together with cagrilintide, an amylin and calcitonin receptor agonist, versus its monotherapies and evaluate the bulk transcriptomic profile of the hypothalamus and the dorsal vagal complex.

INSTRUMENT(S): Illumina NovaSeq 6000

ORGANISM(S): Rattus norvegicus

SUBMITTER: Single Cell Omics Platform CBMR 

PROVIDER: E-MTAB-16695 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2021-03-11 | E-MTAB-10171 | biostudies-arrayexpress
2023-12-31 | E-MTAB-11674 | biostudies-arrayexpress
2020-08-20 | E-MTAB-9425 | biostudies-arrayexpress
2020-08-20 | E-MTAB-9420 | biostudies-arrayexpress
2024-12-21 | E-MTAB-14651 | biostudies-arrayexpress
2017-06-06 | E-MTAB-5731 | biostudies-arrayexpress
2021-11-08 | E-MTAB-11113 | biostudies-arrayexpress
2026-04-01 | E-MTAB-15002 | biostudies-arrayexpress
2021-04-28 | E-MTAB-7006 | biostudies-arrayexpress
2017-04-28 | E-GEOD-68353 | biostudies-arrayexpress